EyePoint, Inc. Current Liabilities
EyePoint, Inc. (EYPT) had Current Liabilities of $41.94 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $41.94M.
- 2026-03-31: Liabilities, Current $37.46M.
- 2025-12-31: Liabilities, Current $37.02M.
- 2025-09-30: Liabilities, Current $30.09M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $41.94M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $37.46M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $37.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $30.09M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $33.17M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $41.68M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $49.05M 10-K · filed 2026-03-05 |
| 2024-09-30 | $48.79M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $62.10M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $62.58M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $63.26M 10-K · filed 2025-03-06 |
| 2023-09-30 | $63.90M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $68.92M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $27.24M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $34.54M 10-K · filed 2024-03-08 |
| 2022-09-30 | $34.26M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $33.39M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $31.97M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $23.66M 10-K · filed 2023-03-10 |
| 2021-09-30 | $19.93M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $16.25M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $13.44M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $14.89M 10-K · filed 2022-03-14 |
| 2020-09-30 | $12.93M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $9.59M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.30M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $11.52M 10-K · filed 2021-03-12 |
| 2019-09-30 | $10.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $10.72M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $24.66M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $21.46M 10-K · filed 2020-03-16 |
| 2018-09-30 | $22.42M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $21.66M 10-KT · filed 2019-03-18 |
| 2018-03-31 | $21.21M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.25M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $4.28M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.29M 10-KT · filed 2019-03-18 |
| 2017-03-31 | $4.94M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $4.93M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $4.84M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $5.09M 10-K · filed 2017-09-13 |
| 2016-03-31 | $3.97M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $3.88M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $2.99M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $3.35M 10-K · filed 2016-09-13 |
| 2015-03-31 | $2.22M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $2.27M 10-Q · filed 2015-02-06 |
| 2014-09-30 | $2.31M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.13M 10-K · filed 2015-09-10 |
| 2014-03-31 | $2.28M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $2.15M 10-Q · filed 2014-02-12 |
| 2013-09-30 | $2.86M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $3.30M 10-K · filed 2014-09-11 |
| 2013-03-31 | $2.69M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $2.08M 10-Q · filed 2013-02-08 |
| 2012-09-30 | $3.46M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $3.18M 10-K · filed 2013-09-27 |
| 2012-03-31 | $2.59M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $2.63M 10-Q · filed 2012-02-09 |
| 2011-09-30 | $3.99M 10-Q/A · filed 2011-11-09 |
| 2011-06-30 | $5.03M 10-K · filed 2012-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |